Exelixis
FDA approves Exelixis’ cancer drug Cabometyx
January 25, 2021Sales and Marketing Cancer, Exelixis
The FDA has approved Exelixis’ Cabometyx (cabozantinib) for patients with advanced renal cell carcinoma (RCC) as a first-line treatment in …
Phase 3 kidney cancer trial of Bristol Myers Squibb’s Opdivo and Exelixis’ Cabometyx meets primary endpoint
April 21, 2020Manufacturing and Production BMS, Bristol-Myers Squibb, Exelixis, bristol myers squibb
Bristol Myers Squibb and Exelixis have announced that the Phase 3 trial investigating the combination of Opdivo (nivolumab) and Cabometyx …
Roche’s immunotherapy lucky streak ends with deaths in trial
April 13, 2018Medical Communications, Research and Development Exelixis, Roche, biotech, drugs, pharma, pharmaceutical, tecentriq
Roche’s Tecentriq had begun to show signs of reviving its hopes in the competitive PD-1/L1 market, succeeding in two Phase …
Ipsen ends P3 trial on liver cancer early due to strong data
January 18, 2018Research and Development Cabometyx, Exelixis, biotech, drugs, ipsen, pharma, pharmaceutical
Ipsen and Exelixis, partners in developing Cabometyx (cabozantinib), have revealed that they have cut short a Phase 3 trial into …
Exelixis’ Cabometyx smashes Pfizer cancer drug in Phase II trial
October 11, 2016Manufacturing and Production, Research and Development Cabometyx, Exelixis, Pfizer, Phase II, Sutent, advanced renal cell carcinoma
Phase II results presented by genomics-based discovery company Exelixis at the European Society for Medical Oncology (ESMO) congresss has put …
Exelixis signs $200 million licensing deal for cancer drug
March 1, 2016Research and Development, Sales and Marketing Cancer, Cometriq, Exelixis, ipsen
Exelixis has signed a licensing agreement with French biotech firm Ipsen for its cancer drug Cometriq (cabozantinib) for an upfront …
Regulus names Stelios Papadopoulos as chairman
June 12, 2013Manufacturing and Production, Research and Development, Sales and Marketing Alnylam, Exelixis, Regulas
Biopharma firm Regulas Therapeutics has named Stelios Papadopoulos chairman of its Board of directors. Papadopoulos assumes the role from John …
